Richard B Womer
Overview
Explore the profile of Richard B Womer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
2167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cash T, Krailo M, Buxton A, Pawel B, Healey J, Binitie O, et al.
J Clin Oncol
. 2023 Aug;
41(30):4724-4728.
PMID: 37651654
JCO Long-term outcomes from Children's Oncology Group study AEWS0031 were assessed to determine whether the survival advantage of interval-compressed chemotherapy (ICC) was maintained over 10 years in patients with localized...
2.
Ahmed S, Witten B, Harmsen W, Rose P, Krailo M, Marcus K, et al.
Int J Radiat Oncol Biol Phys
. 2022 Oct;
115(2):337-346.
PMID: 36302496
Purpose: To identify potential clinical prognostic factors associated with a higher risk of local recurrence in patients with localized pelvic Ewing sarcoma treated with radiation therapy. Methods And Materials: Data...
3.
Hingorani P, Krailo M, Buxton A, Hutson P, Sondel P, Diccianni M, et al.
Eur J Cancer
. 2022 Jul;
172:264-275.
PMID: 35809374
Purpose: Novel effective therapies are urgently needed in recurrent osteosarcoma. GD2 is expressed in human osteosarcoma tumours and cell lines. This study evaluated the disease control rate (DCR) in patients...
4.
Leavey P, Laack N, Krailo M, Buxton A, Randall R, Dubois S, et al.
J Clin Oncol
. 2021 Oct;
39(36):4029-4038.
PMID: 34652968
Purpose: The primary aim of this phase III randomized trial was to test whether the addition of vincristine, topotecan, and cyclophosphamide (VTC) to interval compressed chemotherapy improved survival outcomes for...
5.
Kopp L, Womer R, Schwartz C, Ebb D, Franco V, Hall D, et al.
Cardiooncology
. 2020 Mar;
5:15.
PMID: 32154021
Background: Dexrazoxane protects from lower-cumulative-dose doxorubicin cardiotoxicity, but the effect of dexrazoxane in children with sarcoma treated with higher-cumulative-dose doxorubicin is unknown. Methods: We evaluated children with osteosarcoma (OS) on...
6.
Narayan H, Putt M, Kosaraju N, Paz A, Bhatt S, Plappert T, et al.
Open Heart
. 2019 Jul;
6(1):e001025.
PMID: 31297226
Objective: We sought to determine how sex and dexrazoxane therapy influence cardiac remodelling in children with sarcoma receiving high-dose doxorubicin. Methods: In a retrospective cohort of 85 children with sarcoma...
7.
Adamson P, Veal G, Womer R, Meany H, Bernhardt M, Frazier A, et al.
Pediatr Blood Cancer
. 2019 Feb;
66(6):e27672.
PMID: 30767382
Background: Carboplatin is often adaptively dosed based on glomerular filtration rate (GFR), usually estimated by nuclear medicine tests. At least five pediatric adaptive dosing formulas have been developed. In an...
8.
Isakoff M, Goldsby R, Villaluna D, Krailo M, Hingorani P, Collier A, et al.
Pediatr Blood Cancer
. 2018 Nov;
66(2):e27524.
PMID: 30378256
Background: Patients with recurrent or refractory osteosarcoma have a poor prognosis with less than 30% surviving two years. Eribulin is a synthetic analog of halichondrin B, has a novel mechanism...
9.
Kadhim M, Abol Oyoun N, Womer R, Dormans J
SICOT J
. 2018 Oct;
4:44.
PMID: 30339522
Introduction: Pelvic sarcomas may present with vague symptoms. The aim of this study was to examine the characteristics and clinical presentations of different types of pelvic sarcoma in children. Methods:...
10.
MacFarland S, Sullivan L, States L, Bailey L, Balamuth N, Womer R, et al.
J Pediatr Hematol Oncol
. 2017 Dec;
40(4):e239-e242.
PMID: 29240034
Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor characterized by aggressive local invasion and a syndrome of platelet trapping known as Kasabach-Merritt phenomenon that, through deposition of platelet derived growth...